Timonen T, Saksela E
Clin Exp Immunol. 1976 Mar;23(3):462-70.
The microcytotoxicity assay has been used to study human maternal cell-mediated immunity against foetal lung cells derived from foetal autopsies and amnion cells from full-term deliveries. Cytotoxicity against semi-allogeneic foetal lung cells but not against adult skin fibroblasts was detected in fourteen cases. No cytotoxicity was detected in six mothers tested during the first 15 weeks of gestation whereas 58% of mothers in the 15-17 weeks of gestation (twelve cases) and 88% with more advanced pregnancies (eight cases) were specifically cytotoxic. Cross-reactions against allogeneic foetal lung cells were mainly produced by effector cells from patients with 16-17-week-old pregnancies. No cytotoxicity was detected against semi-allogeneic amnion cells by effector cells from mothers after full-term deliveries. Cytotoxicity was blocked by autologous post-abortum sera in two out of seven cases. The effect of autologous post-abortum sera on non-cytotoxic effector cells was nonspecifically arming in four out of ten cases.
微细胞毒性试验已被用于研究人类母体针对源自胎儿尸检的胎儿肺细胞和足月分娩的羊膜细胞的细胞介导免疫。在14例中检测到对半同种异体胎儿肺细胞的细胞毒性,但对成人皮肤成纤维细胞未检测到细胞毒性。在妊娠前15周检测的6名母亲中未检测到细胞毒性,而在妊娠15 - 17周的母亲中有58%(12例)以及妊娠更晚期的母亲中有88%(8例)具有特异性细胞毒性。针对同种异体胎儿肺细胞的交叉反应主要由妊娠16 - 17周患者的效应细胞产生。足月分娩后母亲的效应细胞未检测到对半同种异体羊膜细胞的细胞毒性。7例中有2例的细胞毒性被自体流产后血清阻断。10例中有4例自体流产后血清对非细胞毒性效应细胞的作用是非特异性增强。